Sarepta Therapeutics (SRPT) Other Non-Current Assets (2010 - 2026)

Sarepta Therapeutics' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $4.1 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 73.55% year-over-year to $4.1 million; the TTM figure through Mar 2026 stood at $4.1 million (down 73.55% YoY), while the FY2025 annual figure was $5.2 million, up 354.47% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $4.1 million, down from $5.2 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $278.6 million in Q1 2022, with the low at $1.1 million in Q4 2024.
• The 5-year median for Other Non-Current Assets is $5.2 million (2025), against an average of $47.6 million.
• The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets jumped 13019.07% in 2022, then tumbled 99.17% in 2024.
• Sarepta Therapeutics' Other Non-Current Assets stood at $2.2 million in 2022, then jumped by 6261.44% to $136.8 million in 2023, then sank by 99.17% to $1.1 million in 2024, then jumped by 354.47% to $5.2 million in 2025, then fell by 20.62% to $4.1 million in 2026.
• Business Quant data shows SRPT's Other Non-Current Assets at $4.1 million in Q1 2026, $5.2 million in Q4 2025, and $73.4 million in Q3 2025.